BlackRock Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

BlackRock Advisors’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,261	Closed	-$24K	–	3759
2015 Q1	$24K	Buy	6,261 +1,107	+21%	+$4.1K	﹤0.01%	3417
2014 Q4	$19K	Hold	5,154	–	–	﹤0.01%	3519
2014 Q3	$14K	Buy	5,154 +326	+7%	+$2.18K	﹤0.01%	3554
2014 Q2	$56K	Buy	4,828 +1,907	+65%	+$21.6K	﹤0.01%	3237
2014 Q1	$41K	Buy	2,921 +267	+10%	+$4.19K	﹤0.01%	3288
2013 Q4	$47K	Buy	2,654 +426	+19%	+$6.92K	﹤0.01%	3260
2013 Q3	$38K	Buy	+2,228	New	+$31.3K	﹤0.01%	3239

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Advisors's MBII Position: Q2 2015 in Review

BlackRock Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2015, closing a stake of 6,261 shares — an estimated $24K sold.

BlackRock Advisors first reported a position in MBII in Q3 2013 and held it in 7 quarters. The position peaked at $56K in Q2 2014. 38 funds tracked by Wall St. Rank hold MBII as of Q2 2015.

BlackRock Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2015 after selling out during the quarter.
BlackRock Advisors sold 6,261 Marrone Bio Innovations, Inc. shares in Q2 2015, an estimated $24K.
BlackRock Advisors first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 7 quarters.
BlackRock Advisors's Marrone Bio Innovations, Inc. position peaked at $56K in Q2 2014.
38 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.